Efficiency of Antibacterial Prophylaxis in Azacitidine Treated Patients

Summary

Infections are a major life-threatening complication in patients with myelodysplastic syndrome (MDS) or acute myeloid leukaemia (AML). Currently there is no guidelines about antibacterial prophylaxis to prevent infections in patients with myelodysplastic syndrome or acute myeloid leukaemia. The investigators will conduct a randomized prospective study to evaluate the benefit of prophylactic antibacterial by levofloxacin on febrile episode in Azacytidine treated patients (MDS and AML).

Timeline

Start

2018-07-18

Primary completion

2024-07-17

Completion

2024-12-29

Drugs

Indications